I want access to CPMS 2.0 and I had no access to CPMS 1.0. What should I do?
CPMS 2.0 is easy to use and navigate and works mainly as a chat like…
CPMS 2.0 is easy to use and navigate and works mainly as a chat like…
Get ready for the EURO-NMD Neuromuscular Neuropathology Webinar Series—an exciting nine-episode journey through the world…
The European Rare Diseases Research Alliance (ERDERA) seeks experts to join its Multistakeholder Advisory Board…
Dear ERN community, In an effort to support the transition from the current CPMS to…
In March 2024, the EAN published a new guideline on the management of amyotrophic lateral…
Dive deep into the world of Neuromuscular Diseases this summer! Join us for not just…
The Ottawa Hospital NeuroMuscular Centre is accepting applications for 1 or 2 year funded Neuromuscular…
Dive deep into the world of Neuromuscular Diseases this summer! Join us for not just…
Fruitful collaboration between patients and clinicians to produce Patient Journeys We are delighted to share…
This conference is endorsed by the Educational Board of ERN EURO-NMD. The Conference Advances in…
The “Inter-ERN Molecular Therapeutic Board in Neurological Channelopathies” represents an inter-ERN initiative, bringing together expertise…
Are you a doctor registered with the French National Medical Association (Conseil National de l’Ordre…